For some patients, traditional medications do not provide adequate relief. That’s where interventional psychiatric care can make a meaningful difference. At Ascend Psychiatry, we offer Transcranial Magnetic Stimulation (TMS) and Spravato® (esketamine) as advanced, evidence-based options for treatment-resistant depression.
TMS is a non-invasive, FDA-approved therapy that stimulates underactive brain circuits, while Spravato provides a carefully monitored, in-office treatment pathway for patients who need a different approach. These therapies are delivered within our structured Five Pillars model, ensuring that advanced treatment is both precise and thoughtfully integrated into comprehensive care.